logo-loader
viewOptiBiotix Health PLC

OptiBiotix inks Thai deal for weight-loss product

The exclusive agreement with Primo Trading opens up a new Asian market for the SlimBiome product

obese man
There is a growing obesity crisis in the developing world

OptiBiotix Health PLC (LON:OPTI) has signed an exclusive distribution deal for its weight loss product in Thailand.

The three-year agreement with Primo Trading will see the Thai company buy a minimum of 500kg of SlimBiome in the first 12 months, rising to 5,000kg by year-three. It has already made an initial 100kg purchase.

The product appears to be gaining commercial traction in Asia with approval in India opening the way for sales into one of the region’s largest markets.

“The growing obesity crisis has opened up an opportunity in these markets for SlimBiome where food supplements and functional holistic products are readily accepted,” said Christina Wood, sales and marketing director at OptiBiotix.”

Thailand, for example, is experiencing an obesity wave with one in three men and 40% of women now classified as overweight. The country is now the second heaviest in Asia after Malaysia, mainly as a result of increasing fast food outlets and high sugar usage throughout the food industry.

Wood went on: “The value gained from our industry awards, clinical studies and recent medical device approval has given our products clear differentiation over other weight loss products.

“The team at Primo have already identified key areas for SlimBiome and are in the process of formulating SlimBiome containing products to meet local tastes.”

OptiBiotix’s discoveries focus on gut health and the growing realisation that changes to the human microbiome are able improve health. As well as weight-loss products it is developing compounds to treat diabetes and high cholesterol.

Quick facts: OptiBiotix Health PLC

Price: 55.5 GBX

AIM:OPTI
Market: AIM
Market Cap: £48.81 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OptiBiotix Health CEO talks significant new China, Hong Kong and North...

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara speaks to Proactive's Andrew Scott after entering into a three-year distribution agreement with Asian product developer and distributor, Pierce Group. This week they've also agreed a non-exclusive license deal for its SlimBiome trademark with...

on 5/5/20

2 min read